Specific Activity Normal Polymorphisms Are Associated With High or Low Factor XIII Genotype/Phenotype Correlations for Coagulation Factor XIII: Specific
暂无分享,去创建一个
[1] R. Suzuki,et al. Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate , 1989, Blut.
[2] P. Board,et al. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. , 1998, Blood.
[3] A. Markham,et al. New Splicing Mutations in the Human Factor XIIIA Gene, Each Producing Multiple Mutant Transcripts of Varying Abundance , 1998, Thrombosis and Haemostasis.
[4] A. Carter,et al. Association of a Common Polymorphism in the Factor XIII Gene with Myocardial Infarction , 1998, Thrombosis and Haemostasis.
[5] A. Markham,et al. Identification of a large deletion, spanning exons 4 to 11 of the human factor XIIIA gene, in a factor XIII-deficient family. , 1998, Blood.
[6] D. Schuppan,et al. Identification of tissue transglutaminase as the autoantigen of celiac disease , 1997, Nature Medicine.
[7] R. Powers,et al. Transglutaminase activity is increased in Alzheimer's disease brain , 1997, Brain Research.
[8] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[9] L. Henke,et al. Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene , 1996, Human Genetics.
[10] M. Pinotti,et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[11] L. Iacoviello,et al. Detection of New Polymorphic Markers in the Factor V Gene: Association with Factor V Levels in Plasma , 1996, Thrombosis and Haemostasis.
[12] A. Stewart,et al. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function , 1995, British journal of haematology.
[13] Y. Song,et al. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates. , 1994, Analytical biochemistry.
[14] L. Pedersen,et al. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] K. Fickenscher,et al. Determination of factor XIII activity by a new photometric assay in plasma and platelets of healthy blood donors. , 1994, Thrombosis research.
[16] M. Paulsson,et al. Transglutaminases: Protein Cross-Linking Enzymes in Tissues and Body Fluids , 1994, Thrombosis and Haemostasis.
[17] C. Peters,et al. Coagulation Factor XIII in Plasma of Patients with Benign and Malignant Gynaecological Tumours , 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[18] A. Evans,et al. Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[19] K. Achyuthan,et al. A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate. , 1992, Analytical biochemistry.
[20] A. Chitolie,et al. Development and evaluation of ELISAs for factor XIIIA and XIIIB subunits in plasma. , 1992, Thrombosis research.
[21] V. Chang,et al. Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase. , 1991, The Journal of biological chemistry.
[22] B. Nusgens,et al. Factor XIII of blood coagulation decreases the susceptibility of collagen precursors to proteolysis. , 1991, Biochimica et biophysica acta.
[23] A. Henney,et al. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[24] D. Mosher,et al. Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. , 1989, The Journal of biological chemistry.
[25] T. L. Moser,et al. Vitronectin is a substrate for transglutaminases. , 1988, Biochemical and biophysical research communications.
[26] B. Gårdlund,et al. Hemostasis in Crohn's disease: low factor XIII levels in active disease. , 1988, Scandinavian journal of gastroenterology.
[27] K. N. Lee,et al. Colorimetric assay of blood coagulation factor XIII in plasma. , 1988, Clinical chemistry.
[28] C. Francis,et al. Rapid Formation of Large Molecular Weight a-Polymers in Cross-Linked Fibrin Induced by High Factor XIII Concentrations , 1987 .
[29] L. Fésüs,et al. Kinetic determination of blood coagulation Factor XIII in plasma. , 1985, Clinical chemistry.
[30] L. Lorand,et al. Human factor XIII: fibrin-stabilizing factor. , 1980, Progress in hemostasis and thrombosis.
[31] R. Doolittle,et al. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. , 1974, Biochemistry.
[32] S. Pizzo,et al. Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. , 1973, The Journal of biological chemistry.
[33] F. Duckert,et al. A Hitherto Undescribed Congenital Haemorrhagic Diathesis Probably Due to Fibrin Stabilizing Factor Deficiency , 1961, Thrombosis and Haemostasis.
[34] L. Lorand,et al. On the Solubility of Fibrin Clots. , 1948, Science.